LillyDirect, the post-prescription dispensing and delivery service provided by Eli Lilly, is planning to scale its service in the UK by extending eligibility for its LillyDirect service to a broader range of private healthcare companies.
The direct to customer platform is currently supported by two contracted dispensing partners, Onescript by Blueco Healthcare and Pharmacy2U.
LillyDirect provides convenient, secure and discreet home delivery of authentic Lilly medicines.
UK pharmacies running private weight management services regulated by the General Pharmaceutical Council (GPhC) or Pharmaceutical Society of Northern Ireland (PSNI) will be eligible.
Khalil Asmar, Vice President Cardiometabolic Health, Lilly UK & Northern Europe, said: “We are pleased to be able to extend eligibility for LillyDirect in the UK, as part of our phased approach to ensure that we can successfully scale the service.
"The aim of LillyDirect is to offer a new option for private UK regulated healthcare companies to support their patients with dispensing and delivery of Lilly medication.”
